Muscle-Kidney Crosstalk in Age-related Kidney Disease

年龄相关性肾脏疾病中的肌肉-肾脏串扰

基本信息

  • 批准号:
    10399649
  • 负责人:
  • 金额:
    $ 47.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary Acute kidney injury (AKI) and chronic kidney disease (CKD) are more prevalent in elderly individuals due to the increased susceptibility to injury and diminished repair capability of the aging kidney. Age-related decline of renal function may reflect multicellular dysfunction that leads to reduced capability of the kidney to repair or regenerate in response to stress. Our group previously identified MG53 as a key component of cell membrane repair, which plays a vital role in protection against AKI. We know that renal proximal tubular epithelia (PTE) contain endogenous MG53 protein. In principle, compromised function of MG53 to repair injury to PTE may be an intrinsic mechanism that contributes to reduced kidney function in aging. We also know that MG53's myokine function in tissue repair is compromised in aging. A loss of the crosstalk from muscle to kidney may constitute an extrinsic mechanism leading to the increased vulnerability of the kidney to function properly during aging. This project is centered on testing the hypothesis that MG53 participates in the multicellular process of aging-related AKI and CKD by maintaining the integrity of PTE cells and facilitating muscle-kidney crosstalk. We have made a novel finding that links MG53's myokine function in control of intracellular Ca signaling to modulation of inflammasome activation associated with kidney injury and fibrosis. Thus, we developed a novel concept that engineering of macrophages with tailored secretion of MG53 can enhance renoprotection via harnessing inflammation and fibrotic remodeling associated with CKD. If proven, these findings can have a significant impact on geriatric medicine research, as chronic inflammation and fibrosis occur during the aging process and can impact the function of many organs including kidney.
项目概要 急性肾损伤(AKI)和慢性肾病(CKD)在老年人中更为常见,因为 衰老的肾脏更容易受伤,修复能力下降。与年龄相关的肾功能衰退 功能可能反映多细胞功能障碍,导致肾脏修复或再生能力下降 以应对压力。我们课题组之前发现MG53是细胞膜修复的关键成分, 在预防 AKI 方面发挥着至关重要的作用。我们知道肾近端肾小管上皮(PTE)含有 内源性 MG53 蛋白。原则上,MG53 修复 PTE 损伤的功能受损可能是一种内在的机制。 导致衰老过程中肾功能下降的机制。我们还知道 MG53 的肌因子功能 组织修复在衰老过程中受到损害。从肌肉到肾脏的串扰损失可能构成外在因素 导致肾脏在衰老过程中正常发挥功能的脆弱性增加的机制。这个项目是 重点测试 MG53 参与衰老相关 AKI 的多细胞过程的假设 通过维持 PTE 细胞的完整性并促进肌肉-肾脏串扰来治疗 CKD。我们写了一本小说 发现将 MG53 的肌因子功能控制细胞内 Ca 信号转导与炎症小体的调节联系起来 与肾损伤和纤维化相关的激活。因此,我们开发了一个新的概念,即工程 具有定制分泌 MG53 的巨噬细胞可以通过利用炎症和 与 CKD 相关的纤维化重塑。如果得到证实,这些发现将对老年医学产生重大影响 医学研究认为,衰老过程中会发生慢性炎症和纤维化,并会影响 包括肾脏在内的许多器官的功能。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Wound Matrix Stiffness Imposes on Macrophage Activation.
伤口基质硬度影响巨噬细胞的激活。
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Duann, Pu;Lin, Pei
  • 通讯作者:
    Lin, Pei
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pei-Hui Lin其他文献

Pei-Hui Lin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pei-Hui Lin', 18)}}的其他基金

Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
  • 批准号:
    10525534
  • 财政年份:
    2022
  • 资助金额:
    $ 47.05万
  • 项目类别:
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
  • 批准号:
    10651843
  • 财政年份:
    2022
  • 资助金额:
    $ 47.05万
  • 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
  • 批准号:
    10244886
  • 财政年份:
    2020
  • 资助金额:
    $ 47.05万
  • 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
  • 批准号:
    9887283
  • 财政年份:
    2020
  • 资助金额:
    $ 47.05万
  • 项目类别:
Ca signaling cross-talk from SR to mitochondria in heart muscle
Ca 信号从 SR 到心肌线粒体的串扰
  • 批准号:
    10265413
  • 财政年份:
    2018
  • 资助金额:
    $ 47.05万
  • 项目类别:
Ca signaling cross-talk from SR to mitochondria in heart muscle
Ca 信号从 SR 到心肌线粒体的串扰
  • 批准号:
    9908165
  • 财政年份:
    2018
  • 资助金额:
    $ 47.05万
  • 项目类别:

相似海外基金

Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
  • 批准号:
    10740665
  • 财政年份:
    2023
  • 资助金额:
    $ 47.05万
  • 项目类别:
Spatiotemporal regulation of polyploidy in zebrafish cardiac tissue regeneration
斑马鱼心脏组织再生中多倍体的时空调控
  • 批准号:
    10736051
  • 财政年份:
    2023
  • 资助金额:
    $ 47.05万
  • 项目类别:
FrostBite-DMR - A new Drug-Free Approach for Treating Type 2 Diabetes Supplemental Request
FrostBite-DMR - 一种治疗 2 型糖尿病的新无药方法补充请求
  • 批准号:
    10748325
  • 财政年份:
    2022
  • 资助金额:
    $ 47.05万
  • 项目类别:
Extracorporeal SuPAR Extraction to Prevent COVID-19-associated Acute Kidney Injury
体外 SuPAR 提取预防 COVID-19 相关的急性肾损伤
  • 批准号:
    10362860
  • 财政年份:
    2021
  • 资助金额:
    $ 47.05万
  • 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
  • 批准号:
    10244886
  • 财政年份:
    2020
  • 资助金额:
    $ 47.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了